Sale!

APOE Gene Alzheimer disease type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The APOE gene Alzheimer’s disease type 2 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify the presence of specific alleles of the APOE gene that are associated with an increased risk of developing Alzheimer’s disease. The APOE gene is instrumental in the metabolism of fats in the body and has three common alleles: ε2, ε3, and ε4. The ε4 allele is linked to a higher risk of Alzheimer’s disease, while the ε2 allele is considered to provide some protection against the condition.

This test is crucial for individuals with a family history of Alzheimer’s disease or those who wish to understand their genetic predisposition to this neurodegenerative disorder. It involves a simple sample collection process, after which the DNA is analyzed to determine the specific APOE alleles present.

The cost of the APOE gene Alzheimer’s disease type 2 genetic test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure and a comprehensive report that explains the results and their implications for the individual’s risk of developing Alzheimer’s disease. It’s an invaluable tool for those seeking early intervention strategies or simply peace of mind regarding their genetic health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

APOE Gene Alzheimer Disease Type 2 Genetic Test

Test Details

The APOE gene is a gene that provides instructions for making a protein called apolipoprotein E. This protein is involved in the metabolism of lipids (fats) in the body, including cholesterol. The APOE gene has three common variants, called 2, 3, and 4. These variants differ in the amino acid sequence of the apolipoprotein E protein they produce.

The APOE 4 variant has been associated with an increased risk of developing Alzheimer’s disease, particularly late-onset Alzheimer’s disease (the most common form of the disease). Individuals who inherit one copy of the APOE 4 variant have an increased risk of developing Alzheimer’s disease, while those who inherit two copies of the variant have an even higher risk.

NGS (next-generation sequencing) genetic testing can be used to analyze an individual’s APOE gene and determine which variants they carry. This information can be used to assess an individual’s risk of developing Alzheimer’s disease and inform medical decision-making. However, it’s important to note that having the APOE 4 variant does not mean that an individual will definitely develop Alzheimer’s disease, and not having the variant does not guarantee that an individual will not develop the disease. Other genetic and environmental factors also play a role in the development of Alzheimer’s disease.

Test Name

APOE Gene Alzheimer Disease Type 2 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for APOE Gene Alzheimer Disease Type 2 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with APOE Gene Alzheimer Disease Type 2

Test Name APOE Gene Alzheimer disease type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for APOE Gene Alzheimer disease type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with APOE Gene Alzheimer disease type 2
Test Details

The APOE gene is a gene that provides instructions for making a protein called apolipoprotein E. This protein is involved in the metabolism of lipids (fats) in the body, including cholesterol. The APOE gene has three common variants, called 2, 3, and 4. These variants differ in the amino acid sequence of the apolipoprotein E protein they produce.

The APOE 4 variant has been associated with an increased risk of developing Alzheimer’s disease, particularly late-onset Alzheimer’s disease (the most common form of the disease). Individuals who inherit one copy of the APOE 4 variant have an increased risk of developing Alzheimer’s disease, while those who inherit two copies of the variant have an even higher risk.

NGS (next-generation sequencing) genetic testing can be used to analyze an individual’s APOE gene and determine which variants they carry. This information can be used to assess an individual’s risk of developing Alzheimer’s disease and inform medical decision-making. However, it’s important to note that having the APOE 4 variant does not mean that an individual will definitely develop Alzheimer’s disease, and not having the variant does not guarantee that an individual will not develop the disease. Other genetic and environmental factors also play a role in the development of Alzheimer’s disease.